Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 11/20 | 0.56 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.54 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.54 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.54 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.48 |
| ▸ | APLNR | P35414 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | CTSH | P09668 | 1/20 | 0.47 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30229695 | 1.00 | REN (0.56) | RENMAPK8MAPK9MAPK10C5AR1 | |
| SCHEMBL30229795 | 0.92 | REN (0.54) | RENMAPK8MAPK9MAPK10CTSL | |
| SCHEMBL30339509 | 0.92 | CTSL (0.51) | RENMAPK8MAPK9MAPK10APLNR | |
| SCHEMBL30504861 | 0.90 | OPRM1 (0.53) | CTSLCTSHCTSSCTSKOPRM1 | |
| SCHEMBL22022379 | 0.90 | OPRM1 (0.53) | CTSLCTSHCTSSCTSKOPRM1 | |
| SCHEMBL30504860 | 0.89 | C5AR1 (0.52) | RENMAPK8MAPK9MAPK10C5AR1 | |
| SCHEMBL16212659 | 0.89 | C5AR1 (0.54) | C5AR1APLNRCTSLCTSHCTSS | |
| SCHEMBL29607547 | 0.87 | REN (0.53) | RENMAPK8MAPK9MAPK10C5AR1 | |
| SCHEMBL30230017 | 0.87 | OPRM1 (0.58) | CTSLCTSHCTSSCTSKOPRM1 | |
| SCHEMBL31409175 | 0.87 | C5AR1 (0.53) | RENC5AR1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11560406-B2 | Anti-androgen peptides and uses thereof in cancer therapy | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2023-01-24 | — | — | US | disclosed |